Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. (Record no. 24792795)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01983 a2200529 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517025032.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201603s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1522-9629 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.pupt.2015.03.003 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Hall, Ian P |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20160321 |
245 00 - TITLE STATEMENT | |
Title | Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Pulmonary pharmacology & therapeutics |
Date of publication, distribution, etc. | Jun 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 37-44 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Inhalation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Asthmatic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Asthma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzamides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluticasone |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Forced Expiratory Volume |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glucocorticoids |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, Immunologic |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, Prostaglandin |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fowler, Andrew V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gupta, Abhya |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tetzlaff, Kay |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nivens, Michael C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sarno, Maria |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Finnigan, Helen A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bateman, Eric D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rand Sutherland, E |
773 0# - HOST ITEM ENTRY | |
Title | Pulmonary pharmacology & therapeutics |
Related parts | vol. 32 |
-- | p. 37-44 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.pupt.2015.03.003">https://doi.org/10.1016/j.pupt.2015.03.003</a> |
Public note | Available from publisher's website |
No items available.